Shunho Stock Confirms Patent Authorization for Synthetic Nicotine Composition

Regulations by 2FIRSTS.ai
May.08.2024
Shunho Stock Confirms Patent Authorization for Synthetic Nicotine Composition
Shunho shares confirm subsidiary Yunnan Xike's patent approval for synthetic nicotine composition in the US for medical business expansion.

On May 6th, an investor asked a question to Shunho shares (003565) on the interactive platform, "It is rumored that the company's shareholding company Yunnan Xike has been granted authorization for the patent 'Synthetic Nicotine Composition' in the United States. This patented technology will be used to expand into the biopharmaceutical sector. Can you confirm this? Does the company or its subsidiaries have any other strategic plans in the field of synthetic biology?

 

Shunho Stock Confirms Patent Authorization for Synthetic Nicotine Composition
Question and answer details | Image source: Interactive Easy

 

Shunho Corporation stated that its affiliated company, Yunnan Xike Technology Co., Ltd., was granted the invention patent "Synthetic Nicotine Composition" in August 2021, and this patent is still valid. The synthetic nicotine composition covered by this patent technology has the advantages of safety, stability, and ease of storage. It can be used in various fields such as low-temperature HNB products, e-cigarettes, nicotine release patches, pharmaceutical synthesis, etc.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Israel Proposes E-Cigarette Tax Reform Expected to Raise 154 million USD Shekels Annually
Israel Proposes E-Cigarette Tax Reform Expected to Raise 154 million USD Shekels Annually
Israel’s Finance Ministry has proposed a 2026 economic reform introducing new taxes and licensing for e-cigarettes. The plan would impose a NIS 1-per-ml tax on vape liquids and NIS 30 per device, abolish VAT exemptions in Eilat, and is expected to generate about NIS 500 million(154 million USD) annually.
Nov.10 by 2FIRSTS.ai
Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation
Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation
According to LBC, a follow-up investigation in Nottingham found that four out of 14 shops visited still sold illegal disposable vapes, six months after the UK Government’s ban took effect. Although fewer retailers appeared to be offering banned products compared with an earlier visit, illegal vapes remain available despite ongoing enforcement efforts.
Dec.03 by 2FIRSTS.ai
AIRSCREAM Unlocks Pan-European Nicotine Pouch Market for B2B Partners with Full-Service EU OEM Solutions
AIRSCREAM Unlocks Pan-European Nicotine Pouch Market for B2B Partners with Full-Service EU OEM Solutions
Showcased at PouchEx Stockholm, AIRSCREAM’s end-to-end OEM ecosystem demonstrates how brands can enter the fast-growing European nicotine pouch market with greater speed, confidence, and regulatory readiness.
Dec.04
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.
Dec.01 by 2FIRSTS.ai
Over 179,000 E-Cigarettes Destroyed in Samut Prakan as Thai Government Tightens Enforcement
Over 179,000 E-Cigarettes Destroyed in Samut Prakan as Thai Government Tightens Enforcement
Thailand’s Office of the Prime Minister, led by Minister Santi Piyatat, has destroyed nearly 179,000 confiscated e-cigarettes and accessories worth 33 million baht (approx. USD 1,020,000) as part of the government’s ongoing campaign for a “Vape-Free Thai Society.”Officials said the action demonstrates Thailand’s strict enforcement of anti-vaping laws and its commitment to protecting youth and public health.
Nov.27 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21